chr14-77578977-G-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_004863.4(SPTLC2):c.460C>A(p.His154Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,613,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H154P) has been classified as Uncertain significance.
Frequency
Consequence
NM_004863.4 missense
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary sensory and autonomic, type 1CInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
- hereditary sensory and autonomic neuropathy type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004863.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPTLC2 | NM_004863.4 | MANE Select | c.460C>A | p.His154Asn | missense | Exon 3 of 12 | NP_004854.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPTLC2 | ENST00000216484.7 | TSL:1 MANE Select | c.460C>A | p.His154Asn | missense | Exon 3 of 12 | ENSP00000216484.2 | ||
| SPTLC2 | ENST00000554901.1 | TSL:1 | c.268C>A | p.His90Asn | missense | Exon 2 of 9 | ENSP00000452189.1 | ||
| SPTLC2 | ENST00000557566.1 | TSL:2 | n.299C>A | non_coding_transcript_exon | Exon 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152056Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461842Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727224 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152056Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74298 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Neuropathy, hereditary sensory and autonomic, type 1C Uncertain:2
The SPTLC2 c.460C>A; p.His154Asn variant (rs1205341271), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 471493). This variant is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. The histidine at codon 154 is moderately conserved, but computational analyses predict that this variant is neutral (REVEL: 0.057). Due to limited information, the clinical significance of this variant is uncertain at this time.
This sequence change replaces histidine, which is basic and polar, with asparagine, which is neutral and polar, at codon 154 of the SPTLC2 protein (p.His154Asn). This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with SPTLC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 471493). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SPTLC2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at